EP3280795
COMBINATION OF CHIMERIC ANTIGEN RECEPTOR THERAPY AND AMINO PYRIMIDINE DERIVATIVES
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
7.4.2016EP published:
24.3.2021EP application number:
16718786.3
EPO information:
European Patent Register
Max expiry date:
6.4.2036
Title:
COMBINATION OF CHIMERIC ANTIGEN RECEPTOR THERAPY AND AMINO PYRIMIDINE DERIVATIVES
Timeline
Today
7.4.2016EP application
24.3.2021EP Publication
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Name:
The Trustees of The University of PennsylvaniaAddress:
3160 Chestnut Street Suite 200, Philadelphia, PA 19104, US
Inventor
Name:
BYRD, JohnAddress:
Columbus, OH 43212, US
Name:
DUBOVSKY, JasonAddress:
Columbus, OH 43235, US
Name:
JOHNSON, AmyAddress:
Dublin, OH 43016, US
Name:
JUNE, Carl, H.Address:
Merion Station, PA 19066, US
Name:
MUTHUSAMY, NatarajanAddress:
Galloway, OH, US
Name:
PORTER, David, L.Address:
Springfield, PA 19064, US
Name:
WASIK, MariuszAddress:
Ardmore, PA 19003, US
Name:
ANGST, DanielaAddress:
4002 Basel, CH
Name:
FRAIETTA, Joseph, A.Address:
Williamstown, NJ 08094, US
Name:
GESSIER, FrancoisAddress:
4002 Basel, CH
Name:
GILL, SaarAddress:
Philadelphia, PA 19106, US
Name:
MAUS, MarcelaAddress:
Lexington, MA 02421, US
Name:
RUELLA, MarcoAddress:
Philadelphia, PA 19143, US
Name:
VULPETTI, AnnaAddress:
4002 Basel, CH
Priority
Number:
201562144188 PDate:
7.4.2015Country:
US
Classification
Categories:
A61K 31/505, A61K 31/506, A61K 45/06, A61P 35/00, A61P 35/02